Arthritis Drugs Archive | 2005

Arthritis Drugs

Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.


Arthritis Drugs - Issue: 10

Investors Cheer, Analysts Caution In Wake of FDA Advisory Panel News

Read Full Article

Panel Recommends Keeping Celebrex, Bextra on the Market;
Says Vioxx May Return

Read Full Article

Researchers Publish Cardiovascular Risk Analysis Of APPROVe Study

Read Full Article

Judge Dismisses Enbrel Negligence Claims, Allows Defect Claims

Read Full Article

Order Dismisses Negligence, Products Claims in Celebrex Suit

Read Full Article

Judge Says Plaintiff Never Intended to Pursue Claims Against Physician, Denies Remand

Read Full Article

Plaintiff Seeks May 31 Trial Setting, as Parties Dispute Discovery in Vioxx Case

Read Full Article

Complaint Says Plaintiffs' Injuries Were Caused by Celebrex, Bextra & Vioxx

Read Full Article




ISSUES BY YEAR




The HarrisMartin VerdicTrack



The HarrisMartin VerdicTrack lets you track verdicts by product, state, defendant, or expert.